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ABSTRACT 
 
A major priority for cancer control agencies is to reduce geographical inequalities in cancer outcomes. 
While the poorer breast cancer survival among socioeconomically disadvantaged women is well 
established, few studies have looked at the independent contribution that area- and individual-level 
factors make to breast cancer survival. Here we examine relationships between geographic 
remoteness, area-level socioeconomic disadvantage and breast cancer survival after adjustment for 
patients’ socio- demographic characteristics and stage at diagnosis.  
Multilevel logistic regression and Markov chain Monte Carlo simulation were  used to analyze 18 568 
breast cancer cases extracted from the Queensland Cancer Registry for women aged 30 to 70 years 
diagnosed between 1997 and 2006 from 478 Statistical Local Areas in Queensland, Australia.  
Independent of individual-level factors, area-level disadvantage was associated with breast-cancer 
survival (p=0.032). Compared to women in the least disadvantaged quintile (Quintile 5), women 
diagnosed while resident in one of the remaining four quintiles had significantly worse survival (OR 
1.23, 1.27, 1.30, 1.37 for Quintiles 4, 3, 2 and 1 respectively).) Geographic remoteness was not related 
to lower survival after multivariable adjustment.  There was no evidence that the impact of area-level 
disadvantage varied by geographic remoteness. At the individual level, Indigenous status, blue collar 
occupations and advanced disease were important predictors of poorer survival.  
A woman’s survival after a diagnosis of breast cancer depends on the socio-economic characteristics 
of the area where she lives, independently of her individual-level characteristics. It is crucial that the 
underlying reasons for these inequalities be identified to appropriately target policies, resources and 
effective intervention strategies. 
 
3 
 
 
 
INTRODUCTION 
Worldwide, breast cancer (BC) is the most commonly diagnosed cancer among women, accounting 
for 23% of total cancer cases in 2008, and is the leading cause of cancer death among women (14% of 
cancer deaths in 2008).[1] Global incidence and mortality rates vary by more than five-fold with 
developed countries often having high incidence but relatively low mortality rates.[1]  
Consistent with other developed countries, [1] BC survival in Australia has improved significantly 
over the last few decades,[2,3] most likely due to earlier detection through mammographic screening 
and advances in both primary and adjuvant BC treatments.[4] 
Despite having one of the highest female BC survival rates in the world,[5] there is significant 
geographical variation in survival in Australia, with poorer prognosis for women diagnosed outside 
urban areas and for those living in socioeconomically disadvantaged regions[6,7,3] even after 
controlling for stage at diagnosis.[8,7] International studies have consistently shown worse survival in 
women with lower levels of education or income, [9] and an inverse association between area-
disadvantage and BC survival.[10-12] Emerging evidence however suggests a temporal narrowing of 
such disparities in some developed countries.[13]  
Due to the potential barriers of distance and access to specialized care, it could be expected that 
women living in more rural and remote areas would have poorer survival. However results have been 
inconclusive.  While studies from Australia report poorer BC survival in rural areas,[6,14] a New 
Zealand study found no geographical differences[15] while a Canadian study found lower survival 
with increasing urbanization.[16]   
Most studies of area-disadvantage and remoteness inequalities in BC survival have used ecological 
measures of neighborhood disadvantage.[10,11,6,12,7] Hence they cannot indicate whether, and to 
what extent, geographical differences are due to individual or area-level effects. Multilevel survival 
models allow for the partitioning and modeling of complex sources of area- and individual-level 
variation and thus enable us to determine whether areas have an impact on breast cancer survival 
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independently of the characteristics of women who live in those areas. When analyzing hierarchical 
event data, these survival models should be used to account for clustering of individuals within the 
same geographical location.[17,18] Until recently however computational requirements have limited 
their use especially for large health-related data sets having long follow up periods and relatively rare 
events.[19,9] 
To date, no known Australian study has used multilevel analysis to describe the relationship between 
BC survival, geographic remoteness, area disadvantage and individual-level socioeconomic status 
(SES). Additionally, there has been only minimal research on whether individual clinical and 
demographic characteristics mediate survival disparities between social groups.[20] This current study 
considers the impact of geographic remoteness and area disadvantage on BC survival among 
Queensland women after adjusting for stage at diagnosis and other individual-level variables. 
Specifically, we aimed to:  
(i) assess whether BC survival varied with a woman’s area of residence while accounting for 
within-area variation in individual effects and between-group variation in area-based factors 
(ii) identify individual-level factors influencing BC survival 
(iii)  explore the impact of area disadvantage and remoteness on survival after controlling for patient 
characteristics,  and  
(iv) investigate the effect of interactions between area-level factors on survival.   
MATERIALS AND METHODS 
Ethical approval to conduct this study was obtained from the University of Queensland Social and 
Behavioral Sciences Ethical Review Committee.  
With appropriate legislative approvals incident cases were extracted from the Queensland Cancer 
Registry (QCR), a state-wide population-based registry to which all confirmed invasive cancers 
diagnosed among Queensland residents must be notified by law. All women aged 30-79 years 
diagnosed with invasive breast cancer (ICD-10: C50) in Queensland between January 1, 1997 and 
December 31, 2006 (inclusive) (n=19 544) were eligible for the study. In situ BC, tumors of unknown 
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size or with unknown lymph node involvement (if size < 20mm) were excluded. The study population 
was limited to females with first primary diagnosis of invasive BC.  
Survival data 
Survival information for the study cohort was examined up to 31st December 2007, providing at least 
one year of follow-up for each woman. Survival was measured in years from date of BC diagnosis to 
date of death or study end point. Since the outcome of interest was survival from breast-cancer, deaths 
from other causes were censored. 
 
Disease spread: A proxy measure of BC stage was used as described previously[21]based on 
routinely available data on tumor diameter and lymph node involvement. Tumors of less than 20 mm 
diameter with no record of lymph node involvement or metastases were classified as localized BC; 
although absence of metastasis could not be confirmed from QCR data. Since it was not possible to 
definitively distinguish between Stages II to IV with the available information, these were collectively 
defined as ‘Advanced BC’ with cancers known to be diagnosed as a result of metastatic disease being 
included in this category.[21] 
Information was obtained from QCR on year and age of diagnosis, marital status, occupation and 
Indigenous status, with the latter being well recorded in the Registry despite some under 
identification[21] (see Table 1 for categories).  
Area-level variables: 
Statistical Local Areas (SLAs) were used as the geographical unit for the area–level analysis (Figure 
1). SLAs are typically based on or aggregate together to form local government areas, for which the 
local governments are responsible for service provision and infrastructure. There were 478 SLAs in 
Queensland in 2006, with location information being used to allocate address information in 
preceding years to the 2006 SLA boundaries, thus removing any impact of temporal changes in 
geographic boundaries.  
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Geographic Remoteness: Remoteness of residence when diagnosed with BC was defined using the 
ARIA+ classification,[22] This purely geographic measure of remoteness is determined by the 
minimum road distance from population localities to different levels of service centres  (see Table 1 
for categories).  
Area disadvantage: This was measured using the Index of Relative Socioeconomic Disadvantage 
(IRSD),[23] which is an area-based measure of SES and considers factors such as the percentage of 
residents in each SLA on a low income, in unskilled occupations, and unemployed (among others).  
The IRSD score was assigned according to the census closest to the diagnosis date and then collapsed 
into five quintiles of increasing advantage (Quintile 1 most disadvantaged). 
Statistical Analysis 
We have utilized a full multilevel regression model for this study. This approach is substantially 
different to adjusting for clustering effects through random effects  as  described in other 
studies[24,25] and sometimes inappropriately referred to as multilevel modeling (synonymous with 
hierarchical regression). Adjusting for clustering entails adjusting the standard errors of estimates for 
the non-independence of data caused by individuals living within neighborhoods[26]. It is a more 
limited approach than multilevel modeling, in which clustering is used in informative ways[26] and 
which allows for the partitioning and modeling of complex sources of area- and individual-level 
variation.  
Since the Cox proportional hazards model does not allow for full multilevel modeling, we used a 
discrete-time approach  and an expanded person-period dataset, in which a sequence of binary 
responses is generated for each person from each event time, which for this analysis was years[27]. 
For example, if a woman dies during the third year after diagnosis then her discrete responses will be 
= (0,0,1), while another women who is censored in the third year will have the  response vector as 
(0,0,0).The discrete-time hazard, h, for interval t and person i is the probability of an event during 
interval t, given that no event has occurred in a previous interval, i.e. hti=Pr(yti = 1 | ysi=0, s<t). This is 
the usual response probability for a binary variable. 
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Multilevel logistic regression  was used to analyze the expanded person-period data set to assess 
whether geographic remoteness and area disadvantage were associated with BC survival after 
adjustment for individual effects. Models were fitted using Markov chain Monte Carlo (MCMC) 
techniques in MLwiN version 2.15 (University of Bristol, United Kingdom)[28] and checked for 
convergence with Raftery-Lewis and Brooks-Draper diagnostic tools. We used 40,000 iterations for 
burn in and 80,000 iterations for parameter estimation. A second-order polynomial (ie. time (years) 
and time-squared) was used to describe the underlying hazard[17]. The Bayesian deviance 
information criterion (DIC),[29] was used to assess model fit with smaller values indicating better fit.   
A three-step analytical approach was used. First, we specified a null model that comprised individuals 
(level 1) nested in SLAs (level 2) without any explanatory factors. A significant SLA-level random 
term (indicated using Wald chi-square)[30] suggests between-SLA variation in BC survival. Second 
patient characteristics (Model 2), and then area-level geographic remoteness (Model 3) or 
neighborhood disadvantage (Model 4) were added. The final model (Model 5) included all 
explanatory variables on all levels simultaneously. These models allowed us to estimate the 
independent contribution of patient- and area -level factors on survival. Interactions between area-
level remoteness and disadvantage were tested (Wald chi-square) by including all second-order terms 
and main effects of these variables in the fully adjusted model. Parameter estimates are presented as 
odds ratios (OR) with their 95% confidence intervals (CI) similar to that reported by other multilevel 
studies[31,18]carried out using non informative priors where Bayesian and maximum likelihood 
estimates are likely to be close.[32] Joint chi-square tests were used to assess the contribution of each 
variable to model fit and the Z test to assess the significance of individual coefficients.   
 
RESULTS 
Study population 
Selected characteristics of the study population are summarized in Table 1. During the study period 
almost half (47%) of 18 568 participants were diagnosed with advanced disease and 1514 women 
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(8%) died due to BC. The mean length of follow-up was 4.3 years (median=4 years, range=0-10 
years). The overall five-year BC survival rate for study participants was 90% (95% CI=90-91%).  
Random effects 
In the multivariable logistic regression analyses (Table 2), the null model (Model 1) showed there was 
significant (p=0.041) variation in BC survival across the SLAs. This area-level variation was 
successively reduced and became non-significant with multivariable adjustment for the remaining 
individual- and area-level effects. About 70% of the total between-SLA variation was explained by 
patient-level factors fitted in Model 2. 
The DIC statistic showed that adding in the individual effects (Model 2) gave significantly improved 
fit compared to the null model (Model 1). Compared to Model 2, adding in area disadvantage (Model 
4) further reduced the DIC by around 5 units; whereas there was no evidence for better fit by adding 
in area-level remoteness. The DIC were similar for Models 2 and 3 and increased for fully adjusted 
Model 5, hence Model 4 was the best fitting model for these data. Regardless of the final model 
chosen, point estimates for the individual-level covariates did not vary markedly across the different 
models. 
Fixed effects 
Geographic remoteness: Since the final model (Model 4) did not include remoteness, there was no 
statistically significant evidence that geographical remoteness was associated with breast cancer 
survival, after adjusting for the other individual- and area-level variables.  
Area-disadvantage: Independent of individual-level factors, area disadvantage was significantly 
associated with breast-cancer specific survival (p = 0.032) in this final model (Model 4). Compared to 
women in the least disadvantaged quintile (Quintile 5), women diagnosed while resident in one of the 
remaining four quintiles had significantly worse survival (OR 1.23, 1.27, 1.30, 1.37 for Quintiles 4, 3, 
2 and 1 respectively). 
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Individual-level factors: At the individual-level, cancer stage, age at diagnosis and Indigenous status 
were significantly associated (p< 0.001) with survival (Model 4, Table 2). Poorer survival across all 
areas of Queensland (irrespective of area-level variables) were seen for patients aged between 30 to34 
or older than 70 compared to those aged 50-54; blue collar workers versus professionals, Indigenous 
women versus non-Indigenous and unmarried (divorced or separated) versus married women. Women 
diagnosed with advanced BC (OR: 4.94, CI: 4.34-5.66, p< 0.001) had a significant survival 
disadvantage relative to those diagnosed with localized tumors. Also BC survival was lowest in the 
first three years after diagnosis and then increased, with a significant quadratic relationship between 
survival and years of follow-up. 
Interaction effects 
Analyses stratified by remoteness or area disadvantage revealed no evidence of geographic variation 
in survival by deprivation categories or that the deprivation effect varied by remoteness status (data 
not shown). Interactions between geographic remoteness and disadvantage were also analysed but 
found not to reach statistical significance at p ≤0.10 using Wald Chi-square test (results not shown). 
Overall fit of the interaction model was poorer (DIC higher by > 12 units) than its main-effects 
counterpart which suggests that the association between deprivation and poorer BC survival was 
similar for women from major cities as for those from rural or remote areas.  
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DISCUSSION 
Using a large population cohort of Queensland women diagnosed with breast cancer, we found that 
the characteristics of the area in which a woman lives, specifically area disadvantage, was related to 
BC survival independently of individual prognostic factors including diagnosis stage.  
While we found significant evidence of a bivariate association between remoteness and BC survival, 
there was no association after adjusting for stage at diagnosis and other individual-level variables. 
Consistent with this we have recently demonstrated that women from remote or rural regions of 
Queensland are more likely to present with late-stage BC,[21] and so this result highlights the 
importance of improving early diagnosis of BC to reduce the existing geographical differences in BC 
survival.[33,8] 
In contrast, the significant bivariate variation in BC survival by area disadvantage remained after 
adjusting for stage at diagnosis. Our previous analysis [21] demonstrated that BC was more likely to 
be diagnosed at an advanced stage among women living in disadvantaged areas; hence these women 
had less favorable survival outcomes. However our current results reveal there is an additional 
survival inequality over and above that caused by stage at diagnosis. This is consistent with widely 
reported gap in BC survival across socio-economic categories found in Australia,[8,7] 
Netherlands,[10,11] USA[9,12] and UK[34] that was moderated but still remained significant after 
controlling for various demographic and prognostic factors  
Lower BC survival in more disadvantaged areas is increasingly thought to reflect the combined effect 
of multiple factors [10,11,14,35,6,3,12,7] such as educational, economic and  socio- cultural factors 
that affect access to early diagnostic and treatment services as well as environmental or lifestyle 
factors that affect  health behavior and disease risk. Routine mammographic screening detects smaller 
low-grade invasive tumors before women become symptomatic, improves therapeutic effectiveness 
[36] and has led to survival benefits among women aged 50-69 years,[37] with significantly improved 
survival for screen-detected tumors.[38] Internationally, relatively disadvantaged women are less 
likely to be screened for BC.[10,9]  Although Australian women living in affluent areas have lower 
11 
 
participation rates in the national publicly-funded BreastScreen Australia screening program,[37] the 
extent of private screening among this group is unknown.  It is also unlikely that access issues related 
to distance [35,39] would entirely explain this effect, since, based on Model 5, the socioeconomic 
gradient in our study persisted after adjusting for area-level remoteness. Some studies have related the 
survival gap to treatment differences across social groups and lower adherence to therapeutic 
guidelines with increasing deprivation.[11,35,12] Deprivation has also been associated with a higher 
prevalence of more aggressive tumors with poorer prognosis.[40] Data on the expression of BC tumor 
biomarkers were  not available for our cohort and could not be included in this analysis. 
Age-related patterns of BC survival in our study are consistent with other reports.[3,41] The survival 
disadvantage for older women (> 75 years) may reflect age-related treatment variations and sub-
optimal clinical management.[34,42] Although relatively rare, breast cancers diagnosed in women 
younger than 35 years are more likely to be detected later [36] when symptomatic [21,41] and to be 
more aggressive, less responsive and with a poorer prognosis.[41]  
While we were limited in our ability to investigate temporal changes in survival, two-year survival 
estimates increased over the three time periods. This is consistent with decreasing Australian [8] and 
international[1] BC mortality rates over time, with these changes generally attributed to earlier 
detection through mass screening and advances in BC treatments.[4] However screening rates were 
relatively stable over the study period[8] suggesting that  better management of invasive BC through 
establishment of clinical protocols[43] and expanded treatment options[44] especially hormonal, 
systemic and targeted therapies may have played a greater role. 
Given their relatively small numbers (1%) in the study cohort, the persistent survival deficit for 
Indigenous women even after controlling for geographic location, stage, patient- and area 
disadvantage highlights both the strength of this effect and the complexity of underlying reasons. 
Indigenous women in Queensland also have lower screening rates than the general population[8] and 
higher risks of advanced BC.[21] These effects are consistent with results of previous national and 
state/territory studies in Australia.[45,46] Probable reasons include a lack of knowledge of symptoms 
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and treatment among Indigenous women, longer diagnostic delays, limited access to and uptake of 
optimal care, corresponding poorer quality of care, more co-morbidities as well as cultural beliefs that 
may act as barriers to health care utilization.[46,45] 
Strengths of this study include having a cohort consisting of all Queensland female breast cancer 
patients diagnosed from 1997 to 2006 with information on stage at diagnosis. All study data were 
collected prospectively for administrative purposes independently of the study hypotheses, thus 
eliminating recall bias. Our methodology specifically allows for the simultaneous estimation of the 
effects of individual- and area-level effects, quantifies area-level variation in survival, and reports on 
both the magnitude and significance of all included explanatory variables.  
Several study limitations should be noted. Investigation of other possible confounders influencing  BC 
survival such as screening history,[10,9] comorbidities,[10] tumor biology,[40]health insurance, [47] 
treatment [47,39,12] or lifestyle [9] was not possible as these data are not collected as part of the 
QCR. Also the individual-level SES variables were restricted to occupation; hence we could not 
control for within-area variations in other relevant sources of socioeconomic inequalities such as 
education and income that may impact outcomes through different mechanisms. [9] This leaves open 
the possibility of residual confounding by unmeasured socioeconomic indicators although our multi-
level strategy allows appropriate adjustment for patient- and area-level disadvantage by contrast to 
ecological designs. Study results could also have been influenced by the lack of sensitivity and 
specificity of our measure of occupation since the “Not stated” group could not be disaggregated into 
more homogenous groups. Cancer-specific estimates were used for the analyses hence inaccuracies in 
cause of death coding may bias results and underestimate actual BC mortality.[48] 
Conclusion 
This study illustrates the significant association between area disadvantage and BC survival, 
independent of stage at diagnosis and other individual-level characteristics. Further study is required 
to disentangle the role of clinical, educational, cultural, demographic and other factors, particularly 
those contributing to socioeconomic differences for Indigenous and disadvantaged women. Achieving 
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equitable cancer care through targeted strategic planning, is a major priority for cancer control 
agencies.[49] Greater understanding of the causes underlying socio-demographic and spatial patterns 
of cancer indicators is important for targeting policies, resources and effective intervention strategies 
to minimize inequalities in BC stage and outcomes.[50] 
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Figure 1: Geographical boundaries of the Statistical Local Areas in Queensland based on the 
2006 Australian Standard Geographical Classification.
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Table 1: Cohort description and survival outcomes for females diagnosed with breast 
cancer during the period 1997-2006  
 
 All breast 
cancer (N) 
Breast cancer deaths (%) 2 yr survival 
(%) 
5 yr survival 
(%) 
     
All women in cohort 18 568 8.2 96.4 [96, 97] 90.3 [90,91] 
     
Area-level variables     
Area-Remoteness Index of Australia (ARIA)  Χ2=9.84, df=3, p=0.022   
Major city 11 255 7.8 96.6 [96, 97] 91.2 [90, 92] 
Inner regional 4037 8.6 96.4 [95, 97] 89.4 [88, 91] 
Outer regional 2580 8.8 95.8 [95, 97] 88.7 [87, 91] 
Remote/Very remote 696 9.2 95.0 [93, 97] 88.4 [85, 91] 
     
Index of Relative Socioeconomic Disadvantage (IRSD)  Χ2=24.75, df=4 ,p<0.001   
Q5 (least disadvantaged) 3019 6.1 97.8 [97, 98] 93.4 [92, 94] 
Q4 4657 8.0 96.7 [96, 97] 90.7 [90, 92] 
Q3 4540 8.4 96.2 [96, 97] 89.7 [89. 91] 
Q2 4198 9.2 95.6 [95, 96] 88.7 [87, 90] 
Q1 (most disadvantaged) 2151 8.9 95.8 [95, 97] 89.9 [88, 91] 
     
Year of diagnosis  Χ2=15.79, df=4, p<0.001   
1997 – 2000 6714 13.9 96.0 [95, 96] 89.4 [89, 91] 
2001 – 2003 5688 8.0 96.5 [96, 97] 90.1 [90, 92] 
2004 - 2006 6166 2.0 96.9 [96, 97] missing 
     
Individual-level variables     
Age  Χ2=75.89, df=4,  p<0.001   
30-34 321 15.3 93.3 [90, 96] 81.5 [76, 86] 
35-39 819 11.4 95.4 [94, 97] 87.4 [84, 90] 
40-44 1624 9.4 95.5 [94, 96] 88.7 [87, 91] 
45-49 2407 6.6 97.5 [97, 98] 92.0 [90, 93] 
50-54 2729 7.7 96.8 [96, 97] 91.3 [90, 92] 
55-59 2815 6.8 97.3 [97, 99] 92.2 [91, 93] 
60-64 2553 6.8 96.9 [96, 98] 91.4 [90, 93] 
65-69 2132 8.3 96.7 [96, 97] 90.4 [89, 92] 
70-74 1801 8.6 96.1 [95, 97] 89.9 [88, 91] 
75-79 1367 11.5 93.2 [92, 94] 86.4 [84, 88] 
Tumor Stage  Χ2=676.57, df=1, p<0.001   
Early 9820 2.8 99.1 [98, 99] 96.9 [96, 97] 
Advanced 8748 14.1 93.3 [93, 94] 82.8 [82, 84] 
     
Indigenous status  Χ2=127.10, df=2, p<0.001   
Non-Indigenous 15 705 9.4 95.9 [95, 96] 89.0 [88, 90] 
Indigenous 202 14.9 91.5 [86, 95]  77.6 [69, 84]  
Not stated 2661 0.5 99.8 [99, 100]   99.4 [99, 100] 
     
Occupation  Χ2=307.85, df=4, p<0.001   
Professional 3749 11.0 95.6 [95, 96] 86.8 [85, 88] 
White collar 3062 12.8 94.3 [93, 95] 85.3 [84, 87] 
Blue collar 715 15.9 92.9 [91, 95] 82.0 [78, 85] 
Not in the labor force 7168 7.8 96.5 [96, 97] 91.3 [91, 92] 
Not stated 3837 1.0 99.5 [99, 100 98.7 [98, 99] 
     
Marital status  Χ2=50.94, df=4 p<0.001   
Married 12 337 7.4 96.9 [96, 97] 91.1 [90, 92] 
Never married 1067 9.1 95.2 [94, 96] 88.3 [86, 91] 
Widowed 2321 11.6 95.0 [94, 96] 87.9 [86, 89] 
Divorced 1702 10.6 95.0 [94, 96] 87.8 [86, 90] 
Separated 568 9.3 95.2 [93, 97] 87.8 [84, 91] 
Unknown 573 1.2 99.4 [98, 100] 98.2 [96, 99] 
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Table 2: Geographic remoteness, area-disadvantage and the odds of mortality due to breast cancer, Queensland, 1997-2006 
 Model 1  Model 2  Model 3  Model 4  Model 5 
Fixed effects    OR 95% CI  OR 95% CI  OR 95% CI  OR 95% CI 
Area-Remoteness Index of Australia                
Major city       1.00 --     1.00 -- 
Inner regional       1.07 0.93, 1.24     1.01 0.90, 1.12 
Outer regional       1.15 1.01, 1.35     1.11 0.96, 1.25 
Remote/Very Remote       1.26 0.95, 1.69     1.18 0.99, 1.53 
p-value       0.060      0.366  
Index of relative socio-economic disadvantage (IRSD)               
Quintile 5 (least disadvantaged)          1.00 --  1.00 -- 
Quintile 4          1.23 1.08 1.56  1.25 1.06, 1.48 
Quintile 3          1.27 1.06, 1.54  1.24 1.04, 1.56 
Quintile 2          1.30 1.09, 1.58  1.27 1.04, 1.51 
Quintile 1 (most disadvantaged)          1.37 1.11, 1.69  1.31 1.07, 1.69 
p-value          0.032   0.047  
               
Time (years after diagnosis)    1.33 1.21, 1.46  1.31 1.22, 1.45  1.33 1.23, 1.44  1.30 1.22, 1.43 
p-value    <0.001   <0.001   <0.001   <0.001  
               
Time-squared ([years after diagnosis]squared)    0.97 0.96, 0.98  0.97 0.96, 0.98  0.97 0.96, 0.97  0.97 0.96, 0.98 
p-value    <0.001   <0.001   <0.001   <0.001  
               
Age (years)               
30-34    1.50 1.10, 2.04  1.47 1.05, 2.05  1.51 1.10, 2.03  1.52 1.12, 2.02 
35-39    1.17 0.91, 1.48  1.15 0.88, 1.48  1.17 0.92, 1.48  1.22 0.96, 1.46 
40-44    1.09 0.88, 1.35  1.07 0.86, 1.33  1.09 0.85, 1.33  1.13 0.95, 1.32 
45-49    0.83 0.67, 1.03  0.82 0.66, 1.02  0.83 0.66, 1.03  0.84 0.74, 1.02 
50-54    1 --  1 --  1 --  1 -- 
55-59    1.08 0.88, 1.3  1.05 0.87, 1.3  1.07 0.84, 1.33  1.12 0.93, 1.27 
60-64    1.41 1.14, 1.73  1.38 1.11, 1.69  1.40 1.12, 1.67  1.43 1.23, 1.74 
65-69    1.83 1.48, 2.25  1.82 1.48, 2.23  1.82 1.47, 2.25  1.90 1.57, 2.36 
70-74    1.95 1.55, 2.43  1.93 1.55, 2.46  1.91 1.52, 2.36  1.99 1.59, 2.42 
75-79    2.40 1.88, 3.01  2.40 1.88, 3.00  2.39 1.89, 2.96  2.40 1.99, 3.09 
p-value    <0.001   <0.001   <0.001   <0.001  
               
Indigenous status               
Non-Indigenous    1.00 --  1.00 --  1.00 --  1.00 -- 
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 Model 1  Model 2  Model 3  Model 4  Model 5 
Fixed effects    OR 95% CI  OR 95% CI  OR 95% CI  OR 95% CI 
Indigenous    1.72 1.17, 2.45  1.63 1.08, 2.34  1.68 1.14, 2.39  1.60 1.12, 2.1 
Not stated    0.09 0.05, 0.14  0.09 0.05, 0.14  0.09 0.05, 0.15  0.09 0.05, 0.13 
p-value    <0.001   <0.001   <0.001   <0.001  
               
Occupation               
Professional    1.00 --  1.00 --  1.00 --  1.00 -- 
White collar    1.05 0.91, 1.21  1.05 0.92, 1.22  1.04 0.9, 1.2  1.03 0.94, 1.15 
Blue collar    1.30 1.04, 1.58  1.29 1.04, 1.57  1.26 1.02, 1.55  1.27 1.08, 1.51 
Not in the labor force    0.48 0.42, 0.56  0.48 0.42, 0.55  0.47 0.41, 0.54  0.47 0.41, 0.54 
Not stated    0.12 0.08, 0.16  0.12 0.08, 0.16  0.11 0.08, 0.16  0.11 0.11, 0.15  
p-value    <0.001   <0.001   <0.001   <0.001  
               
Marital status               
Married    1.00 --  1.00 --  1.00 --  1.00 -- 
Never married    1.04 0.84, 1.28  1.05 0.85, 1.29  1.04 0.83, 1.27  1.04 0.88, 1.23 
Widowed    1.19 1.01, 1.4  1.19 0.98, 1.38  1.18 1.01, 1.37  1.15 0.98, 1.37 
Divorced    1.40 1.19, 1.65  1.42 1.22, 1.66  1.39 1.15, 1.63  1.39 1.22, 1.63 
Separated    1.30 0.98, 1.7  1.30 0.99, 1.74  1.29 0.96, 1.68  1.30 1.02, 1.68 
Unknown    0.84 0.35, 1.60  0.80 0.36, 1.58  0.82 0.34, 1.65  0.77 0.43, 1.85 
p-value    <0.001   <0.001   <0.001   <0.001  
               
Cancer Stage               
early    1 --  1 --  1 --  1 -- 
advanced    4.96 4.37, 5.67  4.94 4.34, 5.62  4.94 4.34, 5.66  4.92 4.43, 5.62 
p-value    <0.001   <0.001   <0.001   <0.001  
               
Random effects               
Area variance & standard error 0.027 0.018  0.008 0.015  0.013 0.015  0.006 0.009  0.009 0.013 
p-value for area variance  0.041  0.389  0.154  0.318  0.391 
Percentage reduction in area variance from the null model --  70.4  51.9  77.8  66.7 
DIC (MCMC modeling, 50, 000 iterations) 22572.34  20906.12  20905.12  20901.28  20904.07 
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